Income Taxes (Tables)

12 Months Ended

Dec. 31, 2023

Income Tax Disclosure [Abstract]

Schedule of (Income) Loss Before Income Taxes

The following table presents the loss (income) before income taxes for the periods presented (in thousands): 

	For the Year Ended December 31,
	2023		2022		2021
Loss (income) attributable to common stockholders	$	1,617,188	$	(175,668)	$	70,152
Loss attributable to noncontrolling interest and redeemable noncontrolling interests	1,078,344		1,023,022		901,107
Loss before income taxes	$	2,695,532	$	847,354	$	971,259

Schedule of Income Tax (Benefit) Provision

The income tax (benefit) provision consists of the following (in thousands):

	For the Year Ended December 31,
	2023		2022		2021
Current
Federal	$	—	$	—	$	—
State	—		—		—
Foreign	—		—		—
Total current (benefit) expense	—		—		—
Deferred
Federal	(23,583)		1,460		13,938
State	10,892		831		(4,667)
Foreign	—		—		—
Total deferred (benefit) provision	(12,691)		2,291		9,271
Total	$	(12,691)	$	2,291	$	9,271

Schedule of Reconciliation of The Statutory Federal Rate

The following table represents a reconciliation of the statutory federal rate and the Company’s effective tax rate for the periods presented:

	For the Year Ended December 31,
	2023		2022		2021
Tax provision (benefit) at federal statutory rate	(21.00)	%	(21.00)	%	(21.00)	%
State income taxes, net of federal benefit	(1.11)		3.42		(2.30)
Effect of noncontrolling and redeemable noncontrolling interests	8.40		25.35		19.48
Stock-based compensation	0.46		1.03		0.29
Tax credits	(0.63)		(1.42)		(0.82)
Effect of valuation allowance	4.06		(7.47)		4.67
Goodwill impairment	9.02		—		—
Other	0.33		0.36		0.63
Total	(0.47)	%	0.27	%	0.95	%

Schedule of Deferred Tax Assets and Liabilities

The following table represents the components of the Company’s deferred tax assets and liabilities for the periods presented (in thousands):

	December 31,
	2023		2022
Deferred tax assets
Accruals and prepaids	$	47,922	$	39,942
Deferred revenue	81,692		70,491
Net operating loss carryforwards	788,507		625,147
Stock-based compensation	12,309		11,327
Investment tax and other credits	122,317		108,107
Interest expense	125,332		16,386
UNICAP costs	110,656		149,873
Total deferred tax assets	1,288,735		1,021,273
Less: Valuation allowance	(174,328)		(61,695)
Gross deferred tax assets	1,114,407		959,578
Deferred tax liabilities
Interest rate derivatives	16,945		20,613
Capitalized costs to obtain a contract	375,226		266,697
Fixed asset depreciation and amortization	580,569		442,656
Deferred tax on investment in partnerships	264,537		362,659
Gross deferred tax liabilities	1,237,277		1,092,625
Net deferred tax liabilities	$	(122,870)	$	(133,047)

Schedule of Tax Years that Remain Open and Subject to Examination by the Tax Authorities

The following table summarizes the tax years that remain open and subject to examination by the tax authorities in the most significant jurisdictions in which the Company operates:

	Tax Years
U.S. Federal	2020 - 2023
State	2019 - 2023